Shearman And Sterling

News Sep 08, 2020

Akcea Therapeutics’ Sale to Ionis Pharmaceuticals

Shearman & Sterling is representing Cowen and Company, LLC as financial advisor to the Affiliate Transactions Committee of Akcea’s Board of Directors in connection with the pending acquisition by Ionis of all of the outstanding shares of Akcea common stock it does not already own, approximately 24%, for $18.15 per share in cash. This corresponds to a total transaction value of approximately $500 million on a fully diluted basis. 

Based in Cambridge, Massachusetts, Akcea is a biopharmaceutical company focused on developing and commercializing medicines to treat patients with serious and rare diseases.

The Team

Regional Experience